All News

Study results also determined that immune system status before treatment may predict outcomes post-treatment.

The drug has been approved to treat patients with advanced or metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer.

Predicting risk for recurrence and progression in patients with nonmuscle-invasive bladder cancer may help when discussing management options with clinicians.

The radioactive diagnostic agent, Gallium 68 PSMA-11, can detect suspected prostate cancer metastasis or recurrence, providing another imaging option for these patients.

Machine learning may be used to predict disease progression in patients with advanced melanoma.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for November 2020.

Several factors may lead to prolonged treatment duration for breast cancer including socioeconomic status, race, and barriers to care.

On social media, in honor of Thanksgiving, CURE® recently asked its readers to share what they are most thankful for this holiday season.

A patient with cancer discusses how the compassionate and encouraging presence of oncology nurses makes a difference in their cancer journey.

A cancer survivor describes how her oncology nurse was by her side through her cancer journey as both a nurse, and her friend.

An oncology nurse recounts how her fellow nurses are compassionate, empathetic and knowledgeable towards patients with cancer.

Women with breast cancer who undergo fertility preservation with breast cancer are more likely to give birth than those who do not, researchers report.

From the National Cancer Institute releasing promising research data into the genomic mutations that helped “exceptional responders” survive on treatment when others didn’t, to a 15-year-old Kentucky cancer survivor dying from COVID-19, here’s what’s happening in the cancer landscape this week.

Here is a list of some recent trials that launched within the cancer space in November.

The Food and Drug Administration’s approval of Danyelza comes as a result of two trials that assessed the efficacy of the drug in patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who did not have sufficient response to prior therapies.

This survival benefit was particularly observed in patients with node-positive disease, or cancer that spread to the lymph nodes according to pathology.

Despite a modest benefit in these patients, principal investigator Dr. Yuan Yuan said she is looking “forward to the future” with regards to therapies that integrate nonsteroidal selective androgen receptor modulators for this patient population.

Living with cancer is not dissimilar to the challenges the COVID-19 pandemic is presenting all of us, but living with cancer during this pandemic is a challenge all to itself, a tough balancing act to pull off.

We have all been told we should stay off our phone before bed, but this study proves that the outdoor light at night is truly harmful long term and could increase the risk of non-Hodgkin lymphoma.

Drugs that target certain gene mutations are improving survival rates for patients with lung cancer.

Patients with mesothelioma are living longer thanks to new drug combinations – including the first FDA-approved regimen in 15 years.

As our understanding of lung cancer broadens, experts are now looking to rare genomic alterations that lead to aggressive lung cancer.

On social media, CURE® recently asked its readers to share their thoughts on what they wish they could change about cancer care.

Oncology nurses provide all kinds of support to patients with cancer, but among the ways they actually deliver care, they also provide patients with a sense of calm.

Oncology nurses can do it all, and the way they help patients with cancer is invaluable.

A cancer survivor recognizes her oncology nurse who has been with her every step of the cancer journey.

A patient with cancer describes how oncology nurses are simply the best for their patients.

From actress Mindy Kaling announcing a partnership with PanCaN to raise awareness for pancreatic cancer after losing her mother to the disease, to Al Roker sharing successful prostate cancer surgery news, here’s what’s happening in the cancer landscape this week.